{"transactions":[{"id":726970,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35485,"kind":"person","name":"Friedman Eric J","position":1,"cik":"0001216280","reported_name":"Friedman Eric J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T16:14:30.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027."}],"balance_after":50000,"derivative":{"exercise_price":0.19,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001216280-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000121628026000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2026-06-24"}},{"id":726969,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T16:07:15.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027."}],"balance_after":50000,"derivative":{"exercise_price":0.2,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000008/primary_doc.xml","form_type":"4"}},{"id":726967,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35485,"kind":"person","name":"Friedman Eric J","position":1,"cik":"0001216280","reported_name":"Friedman Eric J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T15:41:27.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027."}],"balance_after":50,"derivative":{"exercise_price":0.19,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001216280-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000121628026000001/primary_doc.xml","form_type":"4"}},{"id":726968,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T15:29:15.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027."}],"balance_after":50000,"derivative":{"exercise_price":0.19,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001382218-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000138221826000001/primary_doc.xml","form_type":"4"}},{"id":726966,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T15:27:05.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027."}],"balance_after":50000,"derivative":{"exercise_price":0.19,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001443194-26-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319426000006/primary_doc.xml","form_type":"4"}},{"id":806241,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T18:17:24.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":false,"shares":2235417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."}],"balance_after":138667,"source":{"system":"sec-edgar","filing":"0001443194-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319426000005/primary_doc.xml","form_type":"4/A","original_submission_date":"2026-04-17"}},{"id":806240,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T18:17:24.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":false,"shares":8966547,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trustee or Officer"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 138,667 owned by the Reporting Person directly."}],"balance_after":2374084,"source":{"system":"sec-edgar","filing":"0001443194-26-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319426000005/primary_doc.xml","form_type":"4/A","original_submission_date":"2026-04-17"}},{"id":806239,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T16:09:27.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":false,"shares":2235417,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."}],"balance_after":138667,"source":{"system":"sec-edgar","filing":"0001443194-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319426000004/primary_doc.xml","form_type":"4"}},{"id":806238,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T16:09:27.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":false,"shares":8966547,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trustee or Officer"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"2. Includes 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 138,667 owned by the Reporting Person directly."}],"balance_after":2374084,"source":{"system":"sec-edgar","filing":"0001443194-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319426000004/primary_doc.xml","form_type":"4"}},{"id":806237,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":52126,"kind":"person","name":"DESANTIS CARL","position":1,"cik":"0001102948","reported_name":"DESANTIS CARL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T15:58:42.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":false,"shares":2235417,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Reporting Person is deceased"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001102948-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000110294826000002/primary_doc.xml","form_type":"4"}},{"id":806236,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":52126,"kind":"person","name":"DESANTIS CARL","position":1,"cik":"0001102948","reported_name":"DESANTIS CARL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T15:58:42.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":false,"shares":8966547,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Reporting Person is deceased"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."}],"balance_after":2235417,"source":{"system":"sec-edgar","filing":"0001102948-26-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000110294826000002/primary_doc.xml","form_type":"4"}},{"id":806234,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T15:21:53.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":true,"shares":2235417,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":12733058,"source":{"system":"sec-edgar","filing":"0001345281-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000004/primary_doc.xml","form_type":"4"}},{"id":806233,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T15:21:53.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":true,"shares":8966547,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":10497641,"source":{"system":"sec-edgar","filing":"0001345281-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000004/primary_doc.xml","form_type":"4"}},{"id":827670,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":52126,"kind":"person","name":"DESANTIS CARL","position":1,"cik":"0001102948","reported_name":"DESANTIS CARL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T16:24:24.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":false,"shares":7392,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Reporting Person is deceased"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis."}],"balance_after":11366673,"source":{"system":"sec-edgar","filing":"0001102948-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000110294826000001/primary_doc.xml","form_type":"4"}},{"id":827669,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":52126,"kind":"person","name":"DESANTIS CARL","position":1,"cik":"0001102948","reported_name":"DESANTIS CARL","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-26T16:24:24.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":false,"shares":1356293,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Reporting Person is deceased"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 14,709 shares of Common Stock owned by the Estate of Carl DeSantis."}],"balance_after":11374065,"source":{"system":"sec-edgar","filing":"0001102948-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000110294826000001/primary_doc.xml","form_type":"4"}},{"id":828600,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T21:26:44.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":false,"shares":7392,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trustee or Officer"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon\nDeSantis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly."}],"balance_after":11505340,"source":{"system":"sec-edgar","filing":"0001443194-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319426000003/primary_doc.xml","form_type":"4"}},{"id":828599,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T21:26:44.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":false,"shares":1356293,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trustee or Officer"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 9,116,547 shares of Common Stock owned by CD Financial, LLC, 2,242,809 shares of Common Stock owned by the Carl DeSantis Revocable Trust, 14,709 shares of Common Stock owned by the Estate of Carl DeSantis and 138,667 owned by the Reporting Person directly."}],"balance_after":11512732,"source":{"system":"sec-edgar","filing":"0001443194-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319426000003/primary_doc.xml","form_type":"4"}},{"id":828598,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T19:39:16.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":true,"shares":7392,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":1363685,"source":{"system":"sec-edgar","filing":"0001345281-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000001/primary_doc.xml","form_type":"4"}},{"id":828597,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T19:39:16.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":true,"shares":1356293,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":1356293,"source":{"system":"sec-edgar","filing":"0001345281-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000001/primary_doc.xml","form_type":"4"}},{"id":975110,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T22:30:00.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026."}],"balance_after":140000,"derivative":{"exercise_price":0.35,"expiration_date":"2035-12-09","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001064901-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490125000002/primary_doc.xml","form_type":"4"}},{"id":975109,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":false,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T22:25:57.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026."}],"balance_after":140000,"derivative":{"exercise_price":0.35,"expiration_date":"2035-12-09","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001064900-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490025000002/primary_doc.xml","form_type":"4"}},{"id":975108,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T22:09:03.000Z","date":"2025-12-09","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 9, 2026."}],"balance_after":140000,"derivative":{"exercise_price":0.31,"expiration_date":"2035-12-09","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001345281-25-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000011/primary_doc.xml","form_type":"4"}},{"id":1105415,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T18:12:14.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026."}],"balance_after":50000,"derivative":{"exercise_price":0.3,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000009/primary_doc.xml","form_type":"4"}},{"id":1105414,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T18:12:04.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026."}],"balance_after":50000,"derivative":{"exercise_price":0.33,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-25-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000008/primary_doc.xml","form_type":"4"}},{"id":1105413,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35485,"kind":"person","name":"Friedman Eric J","position":1,"cik":"0001216280","reported_name":"FRIEDMAN ERIC J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-20T17:53:45.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026."}],"balance_after":50000,"derivative":{"exercise_price":0.3,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-25-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000007/primary_doc.xml","form_type":"4"}},{"id":1105412,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T17:52:57.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026."}],"balance_after":50000,"derivative":{"exercise_price":0.3,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-25-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000006/primary_doc.xml","form_type":"4"}},{"id":1129757,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-30T20:45:48.000Z","date":"2025-05-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"75% of the options became exercisable on June 2, 2015 with 25% becoming exercisable in twelve (12) equal monthly installments beginning on July 2, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000005/primary_doc.xml","form_type":"4"}},{"id":1129756,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-30T20:45:48.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":138667,"source":{"system":"sec-edgar","filing":"0001345281-25-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000005/primary_doc.xml","form_type":"4"}},{"id":1138020,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-22T21:57:37.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":144445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":144445},"source":{"system":"sec-edgar","filing":"0001345281-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000004/primary_doc.xml","form_type":"4"}},{"id":1138019,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:57:37.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":144445,"price":0.09,"value":13000.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1473467,"source":{"system":"sec-edgar","filing":"0001345281-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000004/primary_doc.xml","form_type":"4"}},{"id":1138018,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T21:56:32.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":144445,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"81,945 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":144445},"source":{"system":"sec-edgar","filing":"0001345281-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000003/primary_doc.xml","form_type":"4"}},{"id":1138017,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:56:32.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":144445,"price":0.09,"value":13000.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"144,445 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1473467,"source":{"system":"sec-edgar","filing":"0001345281-25-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000003/primary_doc.xml","form_type":"4"}},{"id":1138016,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-22T21:41:44.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"72,500 of the options became exercisable on June 2, 2015 and the remaining 62,500 became exercisable in three equal annual installments beginning on June 2, 2016."}],"balance_after":0,"derivative":{"exercise_price":0.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001345281-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000002/primary_doc.xml","form_type":"4"}},{"id":1138015,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-05-22T21:41:44.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0.09,"value":12150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"135,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":347200,"source":{"system":"sec-edgar","filing":"0001345281-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000002/primary_doc.xml","form_type":"4"}},{"id":1138014,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-22T21:09:20.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"75% of the options became exercisable on June 2, 2015 with 25% becoming exercisable in twelve (12) equal monthly installments beginning on July 2, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.09,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001345281-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000001/primary_doc.xml","form_type":"4"}},{"id":1138013,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:09:20.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0.09,"value":15750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"175,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":234233,"source":{"system":"sec-edgar","filing":"0001345281-25-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000001/primary_doc.xml","form_type":"4"}},{"id":1342022,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-05T17:41:50.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.34,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001064901-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490124000001/primary_doc.xml","form_type":"4"}},{"id":1342021,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-05T17:41:37.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.34,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001064900-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490024000002/primary_doc.xml","form_type":"4"}},{"id":1342020,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-05T17:32:16.000Z","date":"2024-12-04","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on December 4, 2025."}],"balance_after":125000,"derivative":{"exercise_price":0.31,"expiration_date":"2034-12-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001345281-24-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000007/primary_doc.xml","form_type":"4"}},{"id":1353164,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T22:09:34.000Z","date":"2024-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55555,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144445,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":55555},"source":{"system":"sec-edgar","filing":"0001064900-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490024000001/primary_doc.xml","form_type":"4"}},{"id":1353163,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-25T22:09:34.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":55555,"price":0.09,"value":4999.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"55,555 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1329022,"source":{"system":"sec-edgar","filing":"0001064900-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490024000001/primary_doc.xml","form_type":"4"}},{"id":1353166,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-25T22:08:54.000Z","date":"2024-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":55555,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144445,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":55555},"source":{"system":"sec-edgar","filing":"0001345281-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000006/primary_doc.xml","form_type":"4"}},{"id":1353165,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-25T22:08:54.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":55555,"price":0.09,"value":4999.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"55,555 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1329022,"source":{"system":"sec-edgar","filing":"0001345281-24-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000006/primary_doc.xml","form_type":"4"}},{"id":1353162,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-25T21:59:37.000Z","date":"2024-11-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":135000,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001345281-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000005/primary_doc.xml","form_type":"4"}},{"id":1353161,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-25T21:59:37.000Z","date":"2024-11-25","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0.09,"value":5850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"65,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":212200,"source":{"system":"sec-edgar","filing":"0001345281-24-000005","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000005/primary_doc.xml","form_type":"4"}},{"id":1438105,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-08T15:49:41.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.18,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000004/primary_doc.xml","form_type":"4"}},{"id":1438104,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35485,"kind":"person","name":"Friedman Eric J","position":1,"cik":"0001216280","reported_name":"FRIEDMAN ERIC J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-08T15:42:11.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.18,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-24-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000003/primary_doc.xml","form_type":"4"}},{"id":1438103,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-08T15:40:30.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.2,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-24-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000002/primary_doc.xml","form_type":"4"}},{"id":1438102,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-08T15:32:29.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.18,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000001/primary_doc.xml","form_type":"4"}},{"id":1728017,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-29T23:44:36.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.26,"expiration_date":"2033-11-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-23-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000009/primary_doc.xml","form_type":"4"}},{"id":1728016,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-29T23:31:12.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.26,"expiration_date":"2033-11-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000008/primary_doc.xml","form_type":"4"}},{"id":1728015,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-29T22:14:37.000Z","date":"2023-11-28","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.24,"expiration_date":"2033-11-28","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-23-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000007/primary_doc.xml","form_type":"4"}},{"id":1739668,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"None of the Options were vested at the time of passing of the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"None of the Options were vested at the time of passing of the Reporting Person."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F6","text":"None of the Options were vested at the time of passing of the Reporting Person."}],"balance_after":0,"derivative":{"exercise_price":0.45,"exercise_date":"2023-11-09","expiration_date":"2023-03-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739667,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Includes 43,333 shares that were not vested at the time of the Reporting Person's passing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Includes 43,333 shares that were not vested at the time of the Reporting Person's passing."}],"balance_after":0,"derivative":{"exercise_price":1.045,"exercise_date":"2022-11-03","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739666,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Includes 33,333 shares that were not vested at the time of the Reporting Person's passing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Includes 33,333 shares that were not vested at the time of the Reporting Person's passing."}],"balance_after":0,"derivative":{"exercise_price":0.72,"exercise_date":"2021-11-04","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739665,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested over three years beginning of the first year anniversary noted herein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Due to the passing of the Reporting Person, the Expiration Date is one year from the date of death."}],"balance_after":0,"derivative":{"exercise_price":0.23,"exercise_date":"2020-05-24","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739664,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":853022,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As sole member of LLC or Trustee of Trusts"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Includes (i) 819,628 shares registered to the name of EGK LLC, an entity the Reporting Person was the sole member of and (ii) 16,697 shares held in each of the Riva Grantor Trust and Christina Kay Grantor Trust whereas the Reporting Person was the Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1739663,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2023-11-16T21:13:09.000Z","date":"2023-03-20","kind":"other","planned":false,"acquired":false,"shares":4299533,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001345281-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000006/primary_doc.xml","form_type":"5"}},{"id":1775789,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T20:17:45.000Z","date":"2023-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001064900-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490023000002/primary_doc.xml","form_type":"4"}},{"id":1775788,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T20:17:45.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":21667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."}],"balance_after":21667,"derivative":{"exercise_price":1.045,"exercise_date":"2022-11-03","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":21667},"source":{"system":"sec-edgar","filing":"0001064900-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490023000002/primary_doc.xml","form_type":"4"}},{"id":1775787,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T20:17:45.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date."}],"balance_after":66667,"derivative":{"exercise_price":0.72,"exercise_date":"2021-11-04","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001064900-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490023000002/primary_doc.xml","form_type":"4"}},{"id":1775786,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T20:17:45.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25,000 vested on May 24, 2019 and 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022."}],"balance_after":150000,"derivative":{"exercise_price":0.23,"exercise_date":"2019-05-24","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001064900-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490023000002/primary_doc.xml","form_type":"4"}},{"id":1775785,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-21T20:17:45.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1273467,"source":{"system":"sec-edgar","filing":"0001064900-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490023000002/primary_doc.xml","form_type":"4"}},{"id":1775784,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-21T20:17:45.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":3410512,"price":0.4,"value":1364204.8,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay and as Trustee of the Emily Sheppard Trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Mrs. Sheppard was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"3,410,512 as Co-Executor of the Estate of E Gerald Kay and 15,700 as Trustee to the Emily Sheppard Trust."}],"balance_after":3426212,"source":{"system":"sec-edgar","filing":"0001064900-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490023000002/primary_doc.xml","form_type":"4"}},{"id":1775783,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775782,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":21667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."}],"balance_after":21667,"derivative":{"exercise_price":1.045,"exercise_date":"2022-11-03","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":21667},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775781,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":66667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"33,334 vested on November 4, 2021, the one year anniversary of the grant date and 33,333 vested on November 4, 2022, the second year anniversary of the grant date."}],"balance_after":66667,"derivative":{"exercise_price":0.72,"exercise_date":"2021-11-04","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":66667},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775780,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25,000 vested on May 24, 2019 and in 41,667 vested each May 24, 2020 and 2021 and 41,666 vested on May 24, 2022."}],"balance_after":150000,"derivative":{"exercise_price":0.23,"exercise_date":"2019-05-24","expiration_date":"2024-03-20","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775779,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-21T19:41:26.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":1273467,"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775778,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-21T19:41:26.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":3410512,"price":0.4,"value":1364204.8,"ownership":{"direct":false,"nature":"As Co-Executor of the Estate of E Gerald Kay"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Date Ms. Kay was appointed Co-Executor of the Estate of E Gerald Kay."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of the Issuer's Common Stock on March 20, 2023, date of transfer into the Estate of E Gerald Kay."}],"balance_after":3410512,"source":{"system":"sec-edgar","filing":"0001064901-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000002/primary_doc.xml","form_type":"4"}},{"id":1775777,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-09-21T14:51:42.000Z","date":"2023-09-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"50,000 stock options disposed of upon exercise of the portion of a stock option grant dated June 2, 2015.  200,000 stock options for the right to purchase common stock at $0.09 remain available to exercise."}],"balance_after":576667,"derivative":{"exercise_price":0.09,"exercise_date":"2015-06-02","expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000004/primary_doc.xml","form_type":"4"}},{"id":1775776,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-09-21T14:51:42.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0.09,"value":4500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"50,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015."}],"balance_after":147200,"source":{"system":"sec-edgar","filing":"0001345281-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000004/primary_doc.xml","form_type":"4"}},{"id":1826074,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-20T19:05:08.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024."}],"balance_after":50000,"derivative":{"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000003/primary_doc.xml","form_type":"4"}},{"id":1827178,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35485,"kind":"person","name":"Friedman Eric J","position":1,"cik":"0001216280","reported_name":"FRIEDMAN ERIC J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T19:34:27.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024."}],"balance_after":50000,"derivative":{"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-23-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000002/primary_doc.xml","form_type":"4"}},{"id":1827177,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T19:27:34.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024."}],"balance_after":50000,"derivative":{"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000001/primary_doc.xml","form_type":"4"}},{"id":1827176,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T19:06:27.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024."}],"balance_after":50000,"derivative":{"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001382218-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000138221823000001/primary_doc.xml","form_type":"4"}},{"id":1872499,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T18:39:07.000Z","date":"2023-05-30","kind":"gift","planned":false,"acquired":true,"shares":50000,"price":0.34,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 50,000 common stock shares acquired upon gift from Heidi Kay, successor owner to Edward Gerald Kay of such shares upon transfer of ownership upon death."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of Common Stock on date of gift, May 30, 2023."}],"balance_after":1811800,"source":{"system":"sec-edgar","filing":"0001064900-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490023000001/primary_doc.xml","form_type":"4"}},{"id":1872497,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-06-01T18:38:37.000Z","date":"2023-05-30","kind":"gift","planned":false,"acquired":true,"shares":50000,"price":0.34,"value":17000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 50,000 common stock shares acquired upon gift from Heidi Kay, successor owner to Edward Gerald Kay of such shares upon transfer of ownership upon death."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of Common Stock on date of gift, May 30, 2023."}],"balance_after":1811800,"source":{"system":"sec-edgar","filing":"0001064901-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490123000001/primary_doc.xml","form_type":"4"}},{"id":2120343,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T23:53:39.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023."}],"balance_after":100000,"derivative":{"expiration_date":"2032-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001064901-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490122000001/primary_doc.xml","form_type":"4"}},{"id":2120342,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T23:47:48.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023."}],"balance_after":100000,"derivative":{"expiration_date":"2032-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001064900-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490022000001/primary_doc.xml","form_type":"4"}},{"id":2120341,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T23:39:23.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be 110% the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023."}],"balance_after":100000,"derivative":{"expiration_date":"2027-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001053310-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000003/primary_doc.xml","form_type":"4"}},{"id":2120340,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-11-10T23:27:50.000Z","date":"2022-11-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023."}],"balance_after":100000,"derivative":{"expiration_date":"2032-11-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-22-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528122000003/primary_doc.xml","form_type":"4"}},{"id":2226031,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T21:33:52.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023."}],"balance_after":50000,"derivative":{"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528122000002/primary_doc.xml","form_type":"4"}},{"id":2226030,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35485,"kind":"person","name":"Friedman Eric J","position":1,"cik":"0001216280","reported_name":"FRIEDMAN ERIC J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:37:12.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023."}],"balance_after":50000,"derivative":{"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001216280-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000121628022000001/primary_doc.xml","form_type":"4"}},{"id":2226029,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:29:38.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023."}],"balance_after":50000,"derivative":{"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001443194-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319422000001/primary_doc.xml","form_type":"4"}},{"id":2226028,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T20:19:15.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023."}],"balance_after":50000,"derivative":{"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001382218-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000138221822000001/primary_doc.xml","form_type":"4"}},{"id":2275206,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-11T18:37:26.000Z","date":"2022-05-06","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested 50% (125,000) on grant date (May 24, 2019) and in three equal annual installments for the remaining 50% (125,000) beginning on May 24, 2020 and ending May 24, 2022."}],"balance_after":150000,"derivative":{"exercise_price":0.23,"expiration_date":"2024-05-24","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001053310-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2022-05-06"}},{"id":2275205,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2022-05-11T18:37:26.000Z","date":"2022-05-06","kind":"exercise","acquired":true,"shares":100000,"price":0.23,"value":23000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being amended to correct the Transaction Code in Table 1 and to include the previously inadvertently omitted disclosure in Table II."},{"field":"security","element":"securityTitle","label":"F2","text":"100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019."}],"balance_after":5345889,"source":{"system":"sec-edgar","filing":"0001053310-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000002/primary_doc.xml","form_type":"4/A","original_submission_date":"2022-05-06"}},{"id":2279728,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Common Stock","published_at":"2022-05-06T21:08:35.000Z","date":"2022-05-06","kind":"grant","acquired":true,"shares":100000,"price":0.23,"value":23000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"100,000 common stock shares acquired upon exercise of stock option grant dated May 24, 2019."}],"balance_after":5345889,"source":{"system":"sec-edgar","filing":"0001053310-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331022000001/primary_doc.xml","form_type":"4"}},{"id":2525057,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":27178,"kind":"person","name":"Milmoe William H.","position":1,"cik":"0001443194","reported_name":"Milmoe William H.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-04T16:22:54.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the \"Issue Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022."}],"balance_after":50000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001443194-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000144319421000001/primary_doc.xml","form_type":"4"}},{"id":2525058,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":52126,"kind":"person","name":"DESANTIS CARL","position":1,"cik":"0001102948","reported_name":"DESANTIS CARL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-04T16:16:43.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the \"Issue Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022."}],"balance_after":50000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001102948-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000110294821000001/primary_doc.xml","form_type":"4"}},{"id":2525056,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-04T14:52:29.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022."}],"balance_after":65000,"derivative":{"expiration_date":"2026-11-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001053310-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000105331021000001/primary_doc.xml","form_type":"4"}},{"id":2527187,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35485,"kind":"person","name":"Friedman Eric J","position":1,"cik":"0001216280","reported_name":"FRIEDMAN ERIC J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T22:51:50.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission(the \"Issue Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022."}],"balance_after":50000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528121000003/primary_doc.xml","form_type":"4"}},{"id":2527186,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T22:46:43.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission (the \"Issue Date\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022."}],"balance_after":50000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528121000002/primary_doc.xml","form_type":"4"}},{"id":2527185,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71936,"kind":"person","name":"Masi Dina","position":1,"cik":"0001345281","reported_name":"Masi Dina","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T22:33:43.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022."}],"balance_after":65000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001345281-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528121000001/primary_doc.xml","form_type":"4"}},{"id":2527183,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71938,"kind":"person","name":"KAY CHRISTINA","position":1,"cik":"0001064901","reported_name":"KAY CHRISTINA","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T22:25:02.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022."}],"balance_after":65000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001064901-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490121000001/primary_doc.xml","form_type":"4"}},{"id":2527184,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":71937,"kind":"person","name":"RIVA SHEPPARD","position":1,"cik":"0001064900","reported_name":"RIVA SHEPPARD","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-11-03T22:07:36.000Z","date":"2021-11-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Exercise Price of the Stock Option will be the closing price of the Issuer's Commons Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022."}],"balance_after":65000,"derivative":{"expiration_date":"2031-11-03","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001064900-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000106490021000001/primary_doc.xml","form_type":"4"}},{"id":2971698,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":52126,"kind":"person","name":"DESANTIS CARL","position":1,"cik":"0001102948","reported_name":"DESANTIS CARL","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T22:18:07.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as follows: 42% (20,831 shares) on November 19, 2020  and in seven equal monthly installments for the remaining 58% (29,169 shares) beginning on December 1, 2020."}],"balance_after":50000,"derivative":{"exercise_price":0.72,"expiration_date":"2030-11-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-20-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528120000008/primary_doc.xml","form_type":"4"}},{"id":2971697,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":108230,"kind":"person","name":"KAY E GERALD","position":1,"cik":"0001053310","reported_name":"KAY E GERALD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman & President"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T22:13:23.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on November 4, 2021."}],"balance_after":100000,"derivative":{"exercise_price":0.72,"expiration_date":"2025-11-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001345281-20-000007","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528120000007/primary_doc.xml","form_type":"4"}},{"id":2971696,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35486,"kind":"person","name":"Canarick Robert","position":1,"cik":"0001382218","reported_name":"Canarick Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T22:07:39.000Z","date":"2020-11-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as follows: 42% (20,831 shares) on November 19, 2020  and in seven equal monthly installments for the remaining 58% (29,169 shares) beginning on December 1, 2020."}],"balance_after":50000,"derivative":{"exercise_price":0.65,"expiration_date":"2030-11-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-20-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528120000006/primary_doc.xml","form_type":"4"}}],"next_cursor":"2020-11-20T22:07:39.000000Z,2971696"}